NovaBridge Biosciences (NBP) Exchange Rate Effect (2019 - 2025)

NovaBridge Biosciences (NBP) reported Exchange Rate Effect of $187000.0 for Q4 2025, up 3216.67% year-over-year from $5638.2 in Q4 2024, and up 156.16% quarter-over-quarter from $73000.0 in Q3 2025.

NovaBridge Biosciences (NBP) Exchange Rate Effect (2019 - 2025) Analysis & Trends

NovaBridge Biosciences (NBP) has 4 years of Exchange Rate Effect data on file, last reported at $187000.0 in Q4 2025.

  • Exchange Rate Effect for Q4 2025 came in at $187000.0, up 3216.67% year-over-year; the trailing twelve-month figure through Dec 2025 was $853000.0 (up 104.21% YoY), and the FY2025 annual result was $276000.0, down 51.83% from the prior year.
  • Exchange Rate Effect advanced to $187000.0 in Q4 2025 per NBP's latest filing, from $73000.0 in the prior quarter.
  • Over five years, Exchange Rate Effect peaked at $599000.0 in Q3 2024 and troughed at -$6000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 3.60 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -2.70 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -40.30 Mn
9 Abivax 90.15 Bn 90.15 Bn - 8.68 Mn
10 NovaBridge Biosciences 328.19 Mn 117.34 Mn - 187,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 187,000.00
Dec 31, 2025 187,000.00
Sep 30, 2025 73,000.00
Sep 30, 2025 73,000.00
Dec 31, 2024 -6,000.00
Dec 31, 2024 -6,000.00
Sep 30, 2024 599,000.00
Sep 30, 2024 599,000.00
Dec 31, 2020 -17.61 Mn
Dec 31, 2020 -17.61 Mn
Sep 30, 2020 -3.23 Mn
Sep 30, 2020 -3.23 Mn
Dec 31, 2019 -8.86 Mn
Dec 31, 2019 -8.86 Mn